AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement
Portfolio Pulse from Nabaparna Bhattacharya
AngioDynamics, Inc. (NASDAQ:ANGO) and Becton, Dickinson And Company (NYSE:BDX) have reached a settlement agreement to resolve their decade-long patent litigation. Under the agreement, BD will license certain port patents to AngioDynamics, and AngioDynamics will license some catheter patents to BD. AngioDynamics will pay BD a lump sum of $7 million, with $3 million paid upfront and the rest over 12 months, plus six annual payments of $2.5 million until February 2029. Additional payments may be required based on AngioDynamics' annual net sales from port products. The settlement aims to reduce legal expenses and distractions for both companies.
April 02, 2024 | 12:52 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AngioDynamics settles patent litigation with Becton, Dickinson, agreeing to a $7M payment plus annual payments until 2029. This settlement aims to reduce legal costs and distractions.
The settlement of the long-standing litigation with Becton, Dickinson is likely to have a positive short-term impact on AngioDynamics' stock. It eliminates the uncertainty and financial burden associated with ongoing legal disputes, potentially improving investor sentiment. The upfront payment and structured annual payments provide financial clarity, which could be viewed positively by investors.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Becton, Dickinson settles with AngioDynamics, receiving a $7M payment plus annual payments until 2029. The settlement ends a decade-long patent litigation.
For Becton, Dickinson, the settlement agreement with AngioDynamics is likely to have a positive short-term impact on its stock. Receiving a lump sum and structured payments can be seen as a financial win, and the resolution of the litigation removes a source of uncertainty. This could lead to improved investor confidence and potentially a positive reaction in the stock market.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80